Elevance Health, Inc.
ELV Real Time Price USD$ELV is featured in our Sheldon Whitehouse strategy.
See All StrategiesRecent trades of ELV by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ELV's directors and management
Government lobbying spending instances
-
$1,220,000 Oct 21, 2024 Issue: Pharmacy Medicare/Medicaid Insurance Health Issues
-
$1,330,000 Jul 22, 2024 Issue: Pharmacy Medicare/Medicaid Insurance Health Issues
-
$2,350,000 Apr 22, 2024 Issue: Pharmacy Medicare/Medicaid Insurance Health Issues
-
$1,460,000 Jan 22, 2024 Issue: Pharmacy Medicare/Medicaid Insurance Health Issues
-
$1,250,000 Nov 06, 2023 Issue: Pharmacy Medicare/Medicaid Insurance Health Issues
-
$1,430,000 Jul 20, 2023 Issue: Pharmacy Medicare/Medicaid Insurance Health Issues
-
$3,640,000 Apr 20, 2023 Issue: Pharmacy Medicare/Medicaid Insurance Health Issues
-
$1,270,000 Jan 20, 2023 Issue: Financial Institutions/Investments/Securities Pharmacy Medicare/Medicaid Insurance Health Issues
-
$1,590,000 Oct 20, 2022 Issue: Financial Institutions/Investments/Securities Pharmacy Medicare/Medicaid Insurance Health Issues
-
$1,570,000 Oct 20, 2022 Issue: Financial Institutions/Investments/Securities Pharmacy Medicare/Medicaid Insurance Health Issues
-
$1,570,000 Jul 20, 2022 Issue: Financial Institutions/Investments/Securities Pharmacy Medicare/Medicaid Insurance Health Issues
-
$50,000 Apr 20, 2022 Issue: Medicare/Medicaid Taxation/Internal Revenue Code Health Issues
-
$60,000 Apr 05, 2022 Issue: Health Issues
-
$30,000 Jan 14, 2022 Issue: Health Issues
-
$30,000 Oct 19, 2021 Issue: Health Issues
-
$680,000 Oct 21, 2019 Issue: Pharmacy Insurance Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
-
$1,110,000 Jul 22, 2019 Issue: Consumer Issues/Safety/Products Insurance Medicare/Medicaid Health Issues Taxation/Internal Revenue Code
-
$730,000 Oct 22, 2018 Issue: Insurance Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Consumer Issues/Safety/Products
-
$2,400,000 Oct 20, 2016 Issue: Labor Issues/Antitrust/Workplace Insurance Medicare/Medicaid Health Issues Taxation/Internal Revenue Code Consumer Issues/Safety/Products
-
$1,050,000 Jul 20, 2016 Issue: Labor Issues/Antitrust/Workplace Insurance Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code Consumer Issues/Safety/Products
-
$1,370,000 May 05, 2016 Issue: Insurance Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code Labor Issues/Antitrust/Workplace Consumer Issues/Safety/Products
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Systems and methods for automated cloud provisioning Oct. 29, 2024
-
Patent Title: System and method for operational workflow transparency and end-to-end events tracking Sep. 10, 2024
-
Patent Title: Smart help platform Aug. 13, 2024
-
Patent Title: Systems and methods for automated cloud provisioning Jul. 16, 2024
-
Patent Title: Methods for evaluating clinical comparative efficacy using real-world health data and artificial intelligence Jan. 30, 2024
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of ELV in WallStreetBets Daily Discussion
Recent insights relating to ELV
Recent picks made for ELV stock on CNBC
ETFs with the largest estimated holdings in ELV
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ELV Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.